NASDAQ:KROS

Keros Therapeutics Stock Predictions

etoro logo Buy KROS
*Your capital is at risk
$10.50
-0.0500 (-0.474%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

KROS Prediction Chart

KROS Predictions History

Latest community submissions for KROS.
Predictor Target Session Target Price Result Direction Accuracy Score
Dec 8, 2025 $21.32 -1.73% $21.32 V 99.98% 10
Dec 8, 2025 $21.46 -1.08% $21.32 V 99.36% 4
Dec 8, 2025 Bullish $21.32 X 0
Apr 14, 2025 $11.88 -2.45% $12.74 X 93.26% 0
Apr 14, 2025 $11.99 -1.53% $12.74 X 94.14% 0
Apr 14, 2025 Bullish $12.74 V 1
Dec 31, 2024 $16.57 +5.95% $15.83 V 95.32% 1
Dec 31, 2024 $17.13 +9.52% $15.83 V 91.79% 1
Dec 31, 2024 Bullish $15.83 X 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for KROS with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT KEROS THERAPEUTICS INC.
Keros Therapeutics
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia in pat...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE